Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Holding JAZZ?
Track your performance easily

Jazz Pharmaceuticals (JAZZ) Ownership - Who Owns Jazz Pharmaceuticals?

1,495 Followers

Jazz Pharmaceuticals (JAZZ) Ownership Overview

3.27%26.36%6.43%27.25%36.68%
6.43% Other Institutional Investors
27.25% ETFs
36.68% Public Companies and Individual Investors
The ownership structure of Jazz Pharmaceuticals (JAZZ) stock is a mix of institutional, retail, and individual investors. Approximately 60.05% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 36.68% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
xxxxxxxxxxxxx
$152703
May 07, 2024
Neena M Patil
Evp & Clo
xxxxxxxxxxxxx
$548250
Mar 08, 2024
Patricia Carr
Svp & Cao
xxxxxxxxxxxxx
$438448
Mar 05, 2024
Philip L Johnson
Evp & Chief Financial Officer
xxxxxxxxxxxxx
$1435800

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,626,096Institution9.31%715,189,324
5,412,435Institution8.95%688,028,737
5,353,307Institution8.86%680,512,386
2,107,589Institution3.49%267,916,714
1,999,090Institution3.31%254,124,321
1,375,460Institution2.28%174,848,475
1,274,248Institution2.11%161,982,406
1,176,106Insider1.95%149,506,595
1,034,909Institution1.71%131,557,632
855,847Institution1.42%108,795,271

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,353,307Institution8.86%680,512,386
1,999,090Institution3.31%254,124,321
855,847Institution1.42%108,795,271
658,517Institution1.09%83,710,681
625,591Institution1.03%79,525,128
597,840Institution0.99%75,997,421
445,882Institution0.74%56,680,520
375,294Institution0.62%47,707,373
326,269Institution0.54%41,475,315
317,978Institution0.53%40,421,363

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,955,920Institution3.24%270,816,683
2,088,436Institution3.45%258,151,574
1,956,458Institution3.24%248,704,941
1,841,800Institution3.05%205,194,938
1,468,410Institution2.43%163,595,558
994,370Institution1.64%110,782,762
924,745Institution1.53%103,025,840
494,766Institution0.82%62,894,654
242,166Institution0.40%30,784,142
247,146Institution0.41%30,549,717

FAQ

Who Owns Jazz Pharmaceuticals (JAZZ)?
According to the latest TipRanks data, approximately 6.43% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 36.68% is held by retail investors.
    What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 6.43% of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors.
      What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors?
      According to the latest TipRanks data, approximately 36.68% of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors.
        Who owns the most shares of Jazz Pharmaceuticals (JAZZ)?
        Vanguard owns the most shares of Jazz Pharmaceuticals (JAZZ).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis